Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA.

Olon is one of the largest European developers and manufacturers, supplying APIs for the pharmaceutical industry worldwide both, for Generic as well as for contract manufacturing. OLON owns 5 manufacturing sites in northern Italy (Rodano, Settimo Torinese, Garbagnate Milanese, Mulazzano and Dorno) with more than 800 employees while INFA Group, with more than 400 employees, has 2 manufacturing sites in Italy, Labochim and Sifavitor, and 1 in Spain, Derivados Químicos.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

F&S Pharmatech is a Nanjing-based pharmaceutical technology company. It provides pharmaceutical intermediates, contract manufacture organization(CMO) service, differentiated API, with intellectual property solutions and environmentally friendly chemical technology to customers in healthcare industry.

Apotex is a Canadian owned pharmaceutical company, and the largest producer of generic medicines in the country. Founded in 1974, the company has focused on research, development, manufacturing and distribution. Apotex has steadily grown to employ over 10,000 people around the world. Apotex Pharmachem is a global, fully integrated API R&D and manufacturing organization with its headquarters located in Brantford, Ontario, and is a member of the Apotex group of companies. Apotex Pharmachem has multiple facilities around the world located in Canada, India, Mexico, and China. Learn more at www.ApotexPharmachem.com.

Watson Laboratories, Inc. develops and markets off-patient and proprietary pharmaceutical products. The company is headquartered in Corona, CA.

Hangzhou Xinbaisi Biopharmaceutical Co., Ltd., established on 2018-09-30, Business scope includes technology research and development,Technical Services,Technology transfer:Pharmaceutical intermediates and raw materials,Biotechnology,chemical reagent,Biochemical reagents,Diagnostic reagents,Organic Polymer Materials,Functional materials and monomers;Research and development of pharmaceutical intermediates,Sales;Chemical raw materials and products(Removal of hazardous chemicals and precursor chemicals),Chemical Equipment,Green facilities,Sales of instrumentation;Import and export business of goods and technology(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Aurisco Pharma is a manufacturer of APIs, FDFs, and CRDMOs of oligonucleotide APIs. It has become a partner of many pharmaceutical firms and has a role in the fields of complex synthesis, synthetic biology, oligonucleotide synthesis, photochemistry, and other disciplines.

Biophore is a developer and manufacturer of pharmaceutical products for the generic industry.

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry. Equipped with a world-class infrastructure manned by best-in-class personnel & driven by the core values of knowledge, innovation and excellence, within a relatively short period, Laurus labs emerged as a segment-leading manufacturer of high quality APIs, a preferred partner for NCE development & manufacture & a trusted source of specialty ingredients for the nutraceutical industry. Given the strengths, capabilities & experience, Laurus Labs is uniquely positioned to help its clients in their endeavor of ‘quicker to market’ & thus contributing towards improving access to quality & affordable healthcare worldwide.

Lianyungang Shengfeng Chemical Co., Ltd., established on 2008-12-24, The scope of business includes the production of chemical products(Triphenylchloromethane,(E)-2-[2-(6-Chloropyrimidine-4-base oxygen)Phenyl]-3-Methyl methoxyacrylate,Biphenoxy diphenyl phosphate,2-hydroxyl-3-Phenylpropiophenone,Azetidine series products,p-Trifluoromethylthiochlorobenzene,4-(2-Methoxyethyl)-2,6-Di-tert-butylphenol,2,3,5,6-Tetrafluoro-p-methoxymethyl benzyl alcohol);Chemical product sales.(None of the above contain hazardous chemicals).***(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Xipu Pharmaceutical Technology Co., Ltd., established on 2010-09-02, The scope of business includes engaging in pharmaceutical,Technology development in the field of chemical science and technology,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Photoelectric material,Packaging Materials,building materials,Instrument sales,Chemical product production(Except for licensed items). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]